Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A SERI® Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair
Status: Enrolling
Updated:  10/5/2017
University of Kentucky
mi
from
Lexington, KY
A SERI® Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair
Status: Enrolling
Updated: 10/5/2017
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)
An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment
Status: Enrolling
Updated:  10/5/2017
USC/LA County
mi
from
Los Angeles, CA
A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)
An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment
Status: Enrolling
Updated: 10/5/2017
USC/LA County
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)
An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment
Status: Enrolling
Updated:  10/5/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)
An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment
Status: Enrolling
Updated: 10/5/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)
An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment
Status: Enrolling
Updated:  10/5/2017
University Hospitals Case Medical Center Seidman Cancer Center
mi
from
Cleveland, OH
A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)
An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment
Status: Enrolling
Updated: 10/5/2017
University Hospitals Case Medical Center Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
ILD Research Center
mi
from
Carlsbad, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
ILD Research Center
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
North Texas Podiatric Medicine and Surgery Associates
mi
from
Dallas, TX
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
North Texas Podiatric Medicine and Surgery Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Texas Gulf Coast Medical Group
mi
from
Webster, TX
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Texas Gulf Coast Medical Group
mi
from
Webster, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
SAVAHCS
mi
from
Tucson, AZ
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
SAVAHCS
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Center for Clinical Research
mi
from
Castro Valley, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Stanford University
mi
from
Stanford, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
SSH
mi
from
South Weymouth, MA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
SSH
mi
from
South Weymouth, MA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Ocean County Foot & Ankle Surgical Associates
mi
from
Toms River, NJ
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Ocean County Foot & Ankle Surgical Associates
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
NSLIJHS
mi
from
Lake Success, NY
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
NSLIJHS
mi
from
Lake Success, NY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
UNC
mi
from
Chapel Hill, NC
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Duke University
mi
from
Durham, NC
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
University Orthopedics
mi
from
Altoona, PA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
University Orthopedics
mi
from
Altoona, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Temple University
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
MedStar Georgetown University Hospital
mi
from
Washington, D.C.,
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
MedStar Georgetown University Hospital
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Barry University Clinical Research
mi
from
North Miami Beach, FL
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Barry University Clinical Research
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
University of Arizona, VAMC
mi
from
Tucson, AZ
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
University of Arizona, VAMC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Uc Irvine Medical Center
mi
from
Orange, CA
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Uc Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
University of Kansas School of Medicine - Veterans Affairs Medical Center
mi
from
Kansas City, MO
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
University of Kansas School of Medicine - Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Columbia University Medical Center
mi
from
New York, NY
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
UNC Center for Functional GI and Motility Disorders
mi
from
Chapel Hill, NC
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
UNC Center for Functional GI and Motility Disorders
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
University Hospitals of Cleveland
mi
from
Cleveland, OH
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Medical University of South Carolina
mi
from
Charleston, SC
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Gastrointestinal Associates
mi
from
Knoxville, TN
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Gastrointestinal Associates
mi
from
Knoxville, TN
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
VAMC Dallas
mi
from
Dallas, TX
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
VAMC Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Tacoma Digestive Disease Research Center
mi
from
Tacoma, WA
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Tacoma Digestive Disease Research Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Harvard, VA Boston Healthcare W Roxbury
mi
from
West Roxbury, MA
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Harvard, VA Boston Healthcare W Roxbury
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated:  10/5/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Ablation of Intestinal Metaplasia Containing Dysplasia
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Status: Enrolling
Updated: 10/5/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Monitoring Movement for Pressure Ulcer Prevention
Monitoring Movement for Pressure Ulcer Prevention
Status: Enrolling
Updated:  10/5/2017
Bakery Square
mi
from
Pittsburgh, PA
Monitoring Movement for Pressure Ulcer Prevention
Monitoring Movement for Pressure Ulcer Prevention
Status: Enrolling
Updated: 10/5/2017
Bakery Square
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Epidemiology of Gallbladder Sludge and Stones in Pregnancy
Epidemiology of Gallbladder Sludge & Stones in Pregnancy
Status: Enrolling
Updated:  10/5/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Epidemiology of Gallbladder Sludge and Stones in Pregnancy
Epidemiology of Gallbladder Sludge & Stones in Pregnancy
Status: Enrolling
Updated: 10/5/2017
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
Status: Enrolling
Updated:  10/6/2017
Rockefeller University
mi
from
New York, NY
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
Status: Enrolling
Updated: 10/6/2017
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity
Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity
Status: Enrolling
Updated:  10/9/2017
Center for Liver Diseases, UPMC.
mi
from
Pittsburgh, PA
Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity
Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity
Status: Enrolling
Updated: 10/9/2017
Center for Liver Diseases, UPMC.
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CYP2C19 Genotype Predictor of Gastric Acid Suppression
CYP2C19 Genotype as a Predictor of Gastric Acid Suppression and Healing of Erosive Esophagitis
Status: Enrolling
Updated:  10/9/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
CYP2C19 Genotype Predictor of Gastric Acid Suppression
CYP2C19 Genotype as a Predictor of Gastric Acid Suppression and Healing of Erosive Esophagitis
Status: Enrolling
Updated: 10/9/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
The Effect of Sucralfate Slurry on Dilated Intercellular Spaces, Tight Junctions, Mucosal Impedance and Mucosal Activity in Patients With Eosinophilic Esophagitis
Status: Enrolling
Updated:  10/9/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
The Effect of Sucralfate Slurry on Dilated Intercellular Spaces, Tight Junctions, Mucosal Impedance and Mucosal Activity in Patients With Eosinophilic Esophagitis
Status: Enrolling
Updated: 10/9/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Comparison of Self-Fixating vs Non-Fixating Hernia Mesh
A Randomized Controlled Study of Self Fixating Mesh Versus Non Fixating Polyester Mesh for Laparoscopic Inguinal Hernia Repair
Status: Enrolling
Updated:  10/10/2017
NorthShore University HealthSystem
mi
from
Evanston, IL
Comparison of Self-Fixating vs Non-Fixating Hernia Mesh
A Randomized Controlled Study of Self Fixating Mesh Versus Non Fixating Polyester Mesh for Laparoscopic Inguinal Hernia Repair
Status: Enrolling
Updated: 10/10/2017
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Status: Enrolling
Updated:  10/11/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Status: Enrolling
Updated: 10/11/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Status: Enrolling
Updated:  10/11/2017
Mayo Clinic
mi
from
Scottsdale, AZ
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Status: Enrolling
Updated: 10/11/2017
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials